Publications by authors named "Bindu Murthy"

Claim this Profile
E
Exposure-Response Modeling and Simulation to Identify Optimal Mavacamten Posology When Coadministered with CYP3A4 and CYP2C19 Inhibitors in Patients with Obstructive HCM.
Samira Merali, Haden Bunn, Caroline Sychterz, Manting Chiang, Shilpa Puli, Bindu Murthy

J Clin Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase.
Praneeth Jarugula, Toni Ajavon-Hartmann, Obinna Obianom, Elizabeth Ludwig, Christina Crevar, Bindu Murthy

Clin Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart Disease.
Antoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, Obinna Obianom, Elizabeth Ludwig, Bindu Murthy

Clin Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Characterization of Cendakimab Administered with Different Devices and at Different Injection Sites in Healthy Participants.
Peijin Zhang, Claudia H M C De Oliveira, Kyungha Yu, Shenita Basdeo, Christina M Charriez, Bindu Murthy

Eur J Drug Metab Pharmacokinet· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Drug Interaction Potential of Mavacamten with Midazolam: Combined Results from Clinical and Model-Based Studies.
Samira Merali, Caroline Sychterz, Vidya Perera, Lu Gaohua, Victoria Florea, Bindu Murthy

J Clin Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study.
Paul Emery, Roy Fleischmann, Robert Wong, Karissa Lozenski, Yoshiya Tanaka, Bindu Murthy

J Rheumatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor.
Sharif I Soleman, Juan Maya, Paul Levesque, Atif Mohammad, Lisa Christopher, Bindu Murthy

Clin Pharmacol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute oral bioavailability of milvexian spray-dried dispersion formulation under fasted and fed conditions in healthy adult participants: An intravenous microtracer approach.
Praneeth Jarugula, Sharif Soleman, Hyunmoon Back, Lisa J Christopher, Dara Hawthorne, Bindu Murthy

Clin Transl Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants.
Samira Merali, Manting Chiang, Caroline Sychterz, Longfei Chao, Tara Simmons, Bindu Murthy

Am J Cardiovasc Drugs· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants.
Vidya Perera, Grigor Abelian, Joseph Luettgen, Ronald Aronson, Danshi Li, Bindu Murthy

Sci Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Based Dose Selection of Subcutaneous Nivolumab in Patients with Advanced Solid Tumors.
Yue Zhao, Kinjal Sanghavi, Amit Roy, Bindu Murthy, Akintunde Bello

Clin Pharmacol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects.
Shan Jing, Yang Lin, Randy Dockens, David Marchisin, Bing He, Bindu Murthy

Dermatol Ther (Heidelb)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute and Relative Bioavailability of Oral Solid Dosage Formulations of Deucravacitinib in Humans.
Anjaneya Chimalakonda, Wenying Li, David Marchisin, Bing He, Shalabh Singhal, Bindu Murthy

Clin Pharmacol Drug Dev· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of safety, pharmacokinetics, and pharmacodynamics of apixaban in pediatric subjects at risk of venous or arterial thrombotic disorder.
Samira J Merali, Wonkyung Byon, Yogesh T Patel, Amira Elsrougy, David Marchisin, Bindu Murthy

CPT Pharmacometrics Syst Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human study of deucravacitinib: A selective, potent, allosteric small-molecule inhibitor of tyrosine kinase 2.
Ian M Catlett, Urvi Aras, Lars Hansen, Yali Liu, Di Bei, Bindu Murthy

Clin Transl Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitor.
Vidya Perera, Zhaoqing Wang, Susan Lubin, Lisa J Christopher, Wei Chen, Bindu Murthy

Sci Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment.
Vidya Perera, Grigor Abelian, Danshi Li, Zhaoqing Wang, Liping Zhang, Bindu Murthy

Clin Pharmacokinet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Itraconazole and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Milvexian, A Factor XIa Inhibitor.
Vidya Perera, Zhaoqing Wang, Susan Lubin, Lisa J Christopher, Wei Chen, Bindu Murthy

Cardiol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants.
Vidya Perera, Grigor Abelian, Danshi Li, Zhaoqing Wang, Liping Zhang, Bindu Murthy

Clin Pharmacokinet· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects.
Anjaneya Chimalakonda, Shalabh Singhal, Raymond Darbenzio, Randy Dockens, David Marchisin, Bindu Murthy

Clin Pharmacol Drug Dev· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and pharmacodynamics of milvexian in healthy Japanese participants.
Vidya Perera, Zhaoqing Wang, Susan Lubin, Takayo Ueno, Tomomi Shiozaki, Bindu Murthy

Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Based Selection and Recommendation for Subcutaneous Abatacept Dose in Patients With Polyarticular Juvenile Idiopathic Arthritis.
Yash Gandhi, Julie A Passarell, Amit Roy, Bindu Murthy

J Clin Pharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition.
Mohammed N Meah, Jennifer Raftis, Simon J Wilson, Vidya Perera, Samira M Garonzik, Bindu Murthy

Arterioscler Thromb Vasc Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study.
Samira Garonzik, Wonkyung Byon, Elsa Myers, Xiodong Li, David Marchisin, Bindu Murthy

Am J Cardiovasc Drugs· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients.
Asha Moudgil, Vikas R Dharnidharka, Daniel I Feig, Barry L Warshaw, Vidya Perera, Bindu Murthy

Am J Transplant· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis